A new HCPLive report frames hidradenitis suppurativa (HS) management around three practical pillars: setting realistic treatment expectations, screening for comorbidities, and structured wound care.

HS is a chronic inflammatory follicular disease that presents with painful nodules, abscesses, sinus tracts, and scarring, typically in intertriginous areas. Long-term management depends heavily on aligning patient expectations with what current therapies can deliver, the report emphasizes, given the disease's relapsing course.

Why do comorbidities matter in HS?

The coverage highlights that HS rarely travels alone. Clinicians are urged to evaluate patients for associated inflammatory and metabolic conditions as part of routine follow-up, since comorbidity burden influences both treatment selection and overall disease monitoring.

What does wound care add to HS treatment?

The report also addresses day-to-day wound management for draining lesions and post-surgical sites, positioning it as a core competency in comprehensive HS care rather than an afterthought to systemic therapy.

The full HCPLive feature outlines clinician-oriented guidance on expectation-setting conversations, comorbidity surveillance, and wound care protocols for dermatology practices managing this burdensome condition.